ClinConnect ClinConnect Logo
Search / Trial NCT06156033

Perioperative Smartwatch Monitoring to Predict Complications

Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · Dec 3, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a smartwatch can help predict complications after major surgeries, like operations on the pancreas or intestines. Researchers want to understand how often patients experience complications after these surgeries and see if the smartwatch can collect useful health information before and after the surgery. Patients who join the study will wear the smartwatch during their hospital stay and will also fill out questionnaires about how they are feeling.

To be eligible for this study, participants need to be at least 18 years old and scheduled for certain types of major surgery under general anesthesia. The trial is open to everyone, regardless of gender. A total of 50 patients will be invited to participate. Those who agree to take part will be closely monitored with the smartwatch, and their feedback will help researchers identify any issues that may arise after surgery. This study aims to improve patient care by catching potential problems early.

Gender

ALL

Eligibility criteria

  • Patients will be recruited prospectively for a total of 50 patients.
  • Inclusion criteria are :
  • Patients scheduled for elective major visceral surgery (pancreatic resection or colorectal surgery) under general anesthesia
  • 18 years of age or older
  • Exclusion criteria will be :
  • - Patient refusal and/or inability to understand and sign informed consent

About Centre Hospitalier Universitaire Vaudois

The Centre Hospitalier Universitaire Vaudois (CHUV) is a leading academic medical center located in Lausanne, Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUV plays a pivotal role in translating scientific discoveries into transformative therapies, enhancing patient care across a diverse range of medical disciplines. With a multidisciplinary team of experts and state-of-the-art facilities, CHUV is dedicated to fostering collaboration and delivering high-quality evidence that informs clinical practice and policy.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Trial Officials

Patrick Schoettker, PD

Study Director

Centre Hospitalier Universitaire Vaudois

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported